• First Patients Undergo Surgery In Northwest Biotherapeutics' Phase II Brain Cancer Trial
  Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB), a biotechnology company focused on cancer immunotherapy, today announced that the first two patients in its pivotal Phase II clinical trial have undergone surgery for newly diagnosed Glioblast
  in Public bookmarks with biotherapeutics biotherapy cancer dcvax-brain dcvax-prostate glioblastoma immunotherapy multiforme news northwest patients pivotal therapy treatment trial by 2 users

immunotherapy from all users